Citizens JMP Remains Bullish on IDEAYA Biosciences (IDYA)
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the best healthcare stocks with the highest upside. Citizens JMP analyst Silvan Tuerkcan released a rating update for IDEAYA Biosciences, Inc.
Ideaya Biosciences Inc. (IDYA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 3,815,704 | $103,825,312 | -25% | 0.17% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 3,275,444 | $89,124,831 | +55% | 0.64% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 2,900,094 | $78,911,558 | +135% | 0.12% |
| 4. | Logos Capital Arsani William | 2,250,000 | $61,222,500 | -33% | 5.49% |
| 5. | Deerfield Management James E. Flynn | 2,153,043 | $58,584,300 | -46% | 0.89% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.32 | 81 | $1,078.63 | 237,475 | 2020-06-30 | Filing | |
| $13.32 | 929 | $12,370.94 | 1,204,981 | 2020-06-30 | Filing | |
| $13.32 | 1,521 | $20,254.24 | 1,667,420 | 2020-06-30 | Filing | |
| $13.93 | 1,354 | $18,867.58 | 237,394 | 2020-06-22 | Filing | |
| $13.93 | 7,854 | $109,443.13 | 1,204,052 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.78 | 851 | $31,296.63 | 0 | 2024-05-29 | Filing | |
| $36.23 | 27,649 | $1,001,587.79 | 851 | 2024-05-29 | Filing | |
| $42.37 | 4,349 | $184,249.73 | 677,887 | 2024-05-16 | Filing | |
| $41.73 | 30,084 | $1,255,504.60 | 682,236 | 2024-05-16 | Filing | |
| $44.12 | 503 | $22,191.30 | 677,887 | 2024-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,146,545 | $357,717,496 | 0.02% | |
| 2. | 8,127,226 | $221,141,808 | 0% | |
| 3. | 6,552,691 | $178,298,722 | 0.03% | |
| 4. | 6,428,339 | $174,931,459 | 0.08% | |
| 5. | 4,922,208 | $133,933,280 | 0% |
News See All
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
J.P. Morgan Remains Bullish on IDEAYA Biosciences (IDYA)
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the best biotech stocks with high potential. On September 23, J.P. Morgan analyst Anupam Rama maintained a bullish stance on IDEAYA Biosciences, Inc.
14 Biotech Stocks with High Potential
Healthcare was the second worst performer this year, with pharma and biotech companies under pressure.
11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds
On September 6, Rebecca Patterson, Chief Investment Strategist at Bridgewater Associates, appeared in an interview on CNBC to discuss the current US economy.
TD Cowen Bullish on Ideaya’s (IDYA) Oncology Pipeline
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the best biotech stocks to buy according to billionaire Steve Cohen.
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen
Steve Cohen, whose success at SAC Capital made him one of the most successful hedge fund managers on Wall Street, is a worried man.
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential
On April 24, Jill Carey Hall, BofA Securities head of U.S. small/mid-cap strategy, appeared on 'Closing Bell' to talk about the impact of tariffs on small caps.
Top 10 AI Trending News on Wall Street
China and the US have been at a crossroads over the past year over access to advanced chips and semiconductor equipment as technological rivalry heats up.
12 Stocks That Will Double in 2025
A lot is happening in the market, especially within the growth sectors.